{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:47:46Z","timestamp":1789714066063,"version":"4.0.1"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T00:00:00Z","timestamp":1487030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0171755","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T19:52:49Z","timestamp":1487101969000},"page":"e0171755","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":58,"title":["Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response"],"prefix":"10.1371","volume":"12","author":[{"given":"Christoph","family":"Welsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Efinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"von Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Zeuzem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania M.","family":"Welzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,2,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.jhep.2015.02.006","article-title":"From non-A, non-B hepatitis to hepatitis C virus cure","volume":"62","author":"JM Pawlotsky","year":"2015","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/emmm.201303131","article-title":"Emerging therapies for the treatment of hepatitis C","volume":"6","author":"CM Lange","year":"2014","journal-title":"EMBO Mol Med"},{"key":"ref3","first-page":"218A","article-title":"Effects of Sustained Virological Response (SVR) on the risk of liver transplant, hepatocellular carcinoma, death and re-infection: meta-analysis of 129 studies in 23,309 patients with Hepatitis C infection","volume":"60","author":"AM Hill","year":"2014","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/hep.22090","article-title":"Serum aminotransferase activity and mortality risk in a United States community","volume":"47","author":"TH Lee","year":"2008","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2013.05.015","article-title":"Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C","volume":"59","author":"T Poynard","year":"2013","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/hep.27766","article-title":"Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes","volume":"62","author":"HA Innes","year":"2015","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1053\/j.gastro.2004.09.050","article-title":"Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels","volume":"127","author":"S Zeuzem","year":"2004","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"D Prati","year":"2002","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.25606","article-title":"A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis","volume":"56","author":"R D'Ambrosio","year":"2012","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"T Poynard","year":"1997","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1517\/14740338.2015.1084287","article-title":"Asunaprevir for hepatitis C: a safety evaluation","volume":"14","author":"I Gentile","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2893.2005.00669.x","article-title":"Hepatitis C and steatosis: a reappraisal","volume":"13","author":"A Lonardo","year":"2006","journal-title":"J Viral Hepat"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0168-8278(02)00299-4","article-title":"Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients","volume":"37","author":"J Westin","year":"2002","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.52.2.288","article-title":"Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies","volume":"52","author":"L Cast\u00e8ra","year":"2003","journal-title":"Gut"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.dld.2003.12.008","article-title":"Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship?","volume":"36","author":"E Bugianesi","year":"2004","journal-title":"Dig Liver Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"S750","DOI":"10.1016\/S0168-8278(16)01461-6","article-title":"Weight gain after IFN-free cure of chronic hepatitis C: A potential concern?","volume":"64","author":"B Schlevogt","year":"2016","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S1590-8658(07)80003-X","article-title":"Natural history of chronic hepatitis C virus infection","volume":"39","author":"A Ascione","year":"2007","journal-title":"Dig Liver Dis"},{"key":"ref18","first-page":"1","article-title":"Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling","volume":"163","author":"AG York","year":"2015","journal-title":"Cell"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the stage of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"ZH Lin","year":"2011","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"14293","DOI":"10.1073\/pnas.1212048109","article-title":"Fueling fibrosis in chronic hepatitis C","volume":"109","author":"R Bataller","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"14562","DOI":"10.1073\/pnas.1210592109","article-title":"Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis","volume":"109","author":"P Farci","year":"2012","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0171755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T04:09:31Z","timestamp":1540267771000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0171755"}},"subtitle":[],"editor":[{"given":"Chen-Hua","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,14]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0171755","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,14]]}}}